G6PD and head and neck squamous cell carcinoma: In this metabolic pathway, glucose-6-phosphate dehydrogenase (G6PD) and transketolase (TKT) are key downstream effectors driven by NRF2, contributing to the progression of head and neck squamous cell carcinoma.